Avrobio Inc

General ticker "AVRO" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $170.8M

Avrobio Inc does not follow the US Stock Market performance with the rate: -16.0%.

Estimated limits based on current volatility of 45.1%: low 5.68$, high 15.00$

Factors to consider:

  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term predictions were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 predicted range: [15.86$, 36.35$]
  • 2024-12-30 to 2025-12-30 predicted range: [15.79$, 36.25$]

Financial Metrics affecting the AVRO estimates:

  • Negative: Non-GAAP EPS of -1.58 <= 0.08
  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: Operating Cash Flow per share of -1.43 <= 0.20
  • Negative: Industry Operating Cash Flow per share (median) of -1.54 <= 0.29
  • Positive: Net Income to Assets ratio of 0.11 > 0.07
  • Negative: Industry Operating Income to Revenue ratio (median) of -0.97 <= 0.02

Similar symbols

Short-term AVRO quotes

Long-term AVRO plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $118.84MM $105.43MM $71.67MM
Operating Income $-118.84MM $-105.43MM $-71.67MM
Non-Operating Income $-0.28MM $-0.46MM $84.20MM
Interest Expense $0.22MM $0.30MM $2.42MM
R&D Expense $83.11MM $72.19MM $47.08MM
Income(Loss) $-119.13MM $-105.89MM $12.53MM
Taxes $0.00MM $0.00MM $0.38MM
Profit(Loss) $-119.13MM $-105.89MM $12.16MM
Stockholders Equity $169.48MM $75.37MM $94.74MM
Assets $203.84MM $103.95MM $101.09MM
Operating Cash Flow $-98.03MM $-97.21MM $-63.19MM
Investing Cash Flow $-2.46MM $-0.27MM $85.08MM
Financing Cash Flow $30.37MM $0.26MM $-16.03MM
Earnings Per Share* $-2.75 $-2.42 $0.27

* EPS are Split Adjusted, recent splits may be reflected with a delay.